177 related articles for article (PubMed ID: 1626600)
1. Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators.
Heimann TM; Oh SC; Martinelli G; Szporn A; Luppescu N; Lembo CA; Kurtz RJ; Fasy TM; Greenstein AJ
Am J Surg; 1992 Jul; 164(1):13-7. PubMed ID: 1626600
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
3. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
4. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
5. DNA quantification in colorectal carcinoma using flow and image analysis cytometry.
Fausel RE; Burleigh W; Kaminsky DB
Anal Quant Cytol Histol; 1990 Feb; 12(1):21-7. PubMed ID: 2405870
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA content abnormalities in young patients with colorectal cancer.
Heimann TM; Martinelli G; Szporn A; Kurtz RJ; Quish A; Miller F; Oh SC; Fasy T
Ann Surg; 1989 Dec; 210(6):792-5. PubMed ID: 2589893
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
10. Improved survival after pulmonary resection of metastatic colorectal carcinoma.
Sauter ER; Bolton JS; Willis GW; Farr GH; Sardi A
J Surg Oncol; 1990 Mar; 43(3):135-8. PubMed ID: 2314100
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content.
Schillaci A; Tirindelli DD; Ferri M; Teodori L; Mauro F; Nicolanti V; Stipa S
Int J Colorectal Dis; 1990 Dec; 5(4):223-7. PubMed ID: 2286806
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
14. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
15. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
16. Correlation of nuclear morphometry and DNA ploidy in rectal cancer.
Heimann TM; Cohen RD; Szporn A; Gil J
Dis Colon Rectum; 1991 Jun; 34(6):449-54. PubMed ID: 2036923
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
18. Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Boeryd B; Nordenskjöld B
APMIS; 1996 Jan; 104(1):35-8. PubMed ID: 8645456
[TBL] [Abstract][Full Text] [Related]
19. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
[TBL] [Abstract][Full Text] [Related]
20. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
